Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. - Wikidata - awgldk - TriplyDB

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

http://www.wikidata.org/entity/Q54580268

about

Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cells Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.Integrating multiple immunogenetic data sources for feature extraction and mining somatic hypermutation patterns: the case of "towards analysis" in chronic lymphocytic leukaemia.Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.A new piece to the stereotypy "puzzle" in chronic lymphocytic leukemia.Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.Identification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patients.Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin Clinical laboratory analysis of immunoglobulin heavy chain variable region genes for chronic lymphocytic leukemia prognosis.B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia.Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia.Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia.Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors.Clonotypic analysis of immunoglobulin heavy chain sequences in patients with Waldenström's macroglobulinemia: correlation with MYD88 L265P somatic mutation status, clinical features, and outcome How I treat CLL up front.Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.Multiparametric analyses of human PBMCs loaded ex vivo with a candidate idiotype vaccine for HCV-related lymphoproliferative disorders.Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia.IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope Peptides that bind specifically to an antibody from a chronic lymphocytic leukemia clone expressing unmutated immunoglobulin variable region genes.Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia.An entity evolving into a community: defining the common ancestor and evolutionary trajectory of chronic lymphocytic leukemia stereotyped subset #4.Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy

P2860

Q23917829-688D33D1-7EEA-49F3-BC5A-9C26C9466C51 Q26782633-E699A682-6567-4074-854C-ABCFAE33E04C Q26823586-5F647233-80CF-4464-B83A-32197D52AE61 Q28077136-0BD18141-BCB4-4A2E-9A23-2BA910793988 Q28245018-C4C95925-F040-4276-AB4E-36C0998F5B56 Q29048163-1CA04C55-ADF1-43B3-A931-78FCA243B4A8 Q29048186-4491788D-8B2B-4F68-ACBE-1E05251694D7 Q30994095-7832E320-38FD-4D79-965E-FE33D689F6F4 Q31107783-FA8EA5A0-B27F-49EF-8AE3-8DDEA3DA11AF Q33350258-0B143A93-63C6-4D4E-8BAE-1A3411CA14A3 Q33361047-5813B6B2-06D9-4956-965F-28FDA6B2E8AA Q33494799-D0A17C39-530B-4999-BA8A-9E8C3D3E1995 Q33634389-A4E0EFA7-2922-44C1-9017-594EF2F4AAAE Q33804706-D66E5A28-044E-420E-97BC-33A36C1089E7 Q33849548-10F5B277-C651-470E-93E0-D26B50D76E2A Q33856248-EDF9179C-B0D8-4663-B59C-090F08EFFC19 Q33878649-E734B5C5-24E0-40B6-B15A-C9EB0A9546B2 Q33886052-5A018D08-C47C-49CE-A0E5-BF64F7DB392D Q34012864-8A523917-A522-4253-8AD5-8DCD9E0BE8B5 Q34056568-6D34C996-987F-4045-9A38-49871B4FABBF Q34095630-8A590508-488D-4AC6-A0E1-0087D55B90AA Q34101118-BE6045EE-975A-47C8-86B8-6D3FCCE662BE Q34137158-5035542C-6A70-41AE-950B-106A4BD82547 Q34166551-75E931D2-D5CA-4879-9569-76B05532D0C1 Q34245048-6A02065D-5567-436A-9EAF-C17B56B55BC4 Q34371084-683FC8E8-AF2F-4AE2-B112-5D02B958B5D3 Q34427560-5E4109C7-8A48-4546-89FA-BC760370C27B Q34463658-9782BBAD-C378-4E37-BFB5-286BFF5FC6FC Q34804388-4F548EAD-DB26-4F9B-97AB-692056003F71 Q34901206-300A9669-1EE2-4E37-BD41-265105FEDF81 Q35029461-FB86E1A4-05EF-48E0-8D61-0585015499B8 Q35136742-1B903DDC-F560-4B6C-B601-ABA59D2844B1 Q35146301-BCB8A910-AB07-4B8C-BA9C-1EA91DAC5422 Q35192691-3446AB27-BE38-4F4B-8208-4B7E36746DC7 Q35434973-AFF29D06-2726-494B-A9A2-8DCDDB52929B Q35528659-592FEA40-CC04-4A8F-B7C5-942614CAE1B1 Q35584788-E4F0B6D5-BA45-419C-86CC-9910DB1489D3 Q35671227-AA5816A7-EDCB-4BD0-BF22-7A23DB927AF7 Q35692395-8BEB69E9-60D1-42B3-8631-9054A532ADD9 Q35747546-61616F8A-2F6D-405A-9A15-3E4439CAE5AA

P2860

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

http://www.wikidata.org/entity/Q54580268

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Over 20% of patients with chro ...... ons and clinical correlations.

@en

Over 20% of patients with chro ...... ons and clinical correlations.

@nl

type

label

Over 20% of patients with chro ...... ons and clinical correlations.

@en

Over 20% of patients with chro ...... ons and clinical correlations.

@nl

prefLabel

Over 20% of patients with chro ...... ons and clinical correlations.

@en

Over 20% of patients with chro ...... ons and clinical correlations.

@nl

P1433

Q54580268-959B714E-5A67-47E2-8A31-13E59E8367BB

P1476

Q54580268-FED59603-5510-41DE-8602-D9AFDF81B56A

P2093

Q54580268-3017C36C-28C0-4ABD-9BD6-D18E63EF9B8A

Q54580268-6883A9F6-CBE8-4ACB-957A-AF87BBA2503F

Q54580268-899ADDEF-1FC9-49AF-BA28-46C68A0B10DC

Q54580268-94BBAB6E-6CD8-461F-AE9D-3E6CDD960D43

Q54580268-974BB5B4-3E7C-4E8E-B784-22F1E67AA4B4

Q54580268-B9246731-5DC2-4059-B6AB-BCDE456E7091

Q54580268-BF679F4E-D2E4-4612-BDE3-359C020E3D33

Q54580268-C77DD4B9-D249-457E-85C8-8DCBB8D9264C

Q54580268-CCEA364B-E531-473E-B2DB-D1A612FAE5A9

Q54580268-CDEA2CAA-123E-4964-A491-BB29B93A41BB

P304

Q54580268-A2329099-B406-4CF1-A520-457CB85EE1E4

P31

Q54580268-028DA421-44D5-4619-80A3-326479383343

P356

Q54580268-67AF1764-80EE-4784-907F-AB22075E7B58

P407

Q54580268-490BC7EB-15A1-4F15-AC9E-DBBDB5376005

P433

Q54580268-D75B2802-D0DE-43CF-9CCD-03C0D33732BF

P478

Q54580268-B3BE9ED3-EAC1-496A-9656-12BF06990C3A

P50

Q54580268-0D2D6156-A3A8-4869-B0C5-F696C0D7D0C8

Q54580268-0FFE00A8-1E4A-49AE-BA3E-E3B778C493F1

Q54580268-11A76814-99A6-4AA6-BE57-4C220C26793E

Q54580268-B0D101B9-78FA-4241-B7A7-CE53848E6BB8

Q54580268-F1B5CFAF-2133-44B1-8E55-F215493966C8

P577

Q54580268-629F03C8-A211-4EE0-A0BC-97CFBB8683F4

P5875

Q54580268-F46487EC-94E6-488E-AC3A-1174B8DA0272

P698

Q54580268-9ED403D5-018F-488C-BCE9-19155C53FE73

P921

Q54580268-4E767B13-58CB-4FD2-8816-49731CF2B58A

Q54580268-724987F2-CBAE-45FF-BDB4-FB51A850DC95

Q54580268-BF3B86B8-8983-40E0-8C2A-9E73C63E711E

P356

BLOOD-2006-03-012948

P1433

P1476

Over 20% of patients with chro ...... ons and clinical correlations.

@en

P2093

Anastasia Hadzidimitriou

http://www.w3.org/2001/XMLSchema#string

Athanasios Fassas

http://www.w3.org/2001/XMLSchema#string

Carol Moreno

http://www.w3.org/2001/XMLSchema#string

Chrysoula Belessi

http://www.w3.org/2001/XMLSchema#string

Emili Montserrat

http://www.w3.org/2001/XMLSchema#string

Federico Caligaris-Cappio

http://www.w3.org/2001/XMLSchema#string

Frédéric Davi

http://www.w3.org/2001/XMLSchema#string

Giuseppe Guida

http://www.w3.org/2001/XMLSchema#string

Guillaume Dighiero

http://www.w3.org/2001/XMLSchema#string

Kostas Stamatopoulos

http://www.w3.org/2001/XMLSchema#string

P304

259-270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2006-03-012948

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Hélène Merle-Béral

Achilles Anagnostopoulos

P577

2006-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6809609

http://www.w3.org/2001/XMLSchema#string

P698

16985177

http://www.w3.org/2001/XMLSchema#string

P921